NCT04165512View on ClinicalTrials.gov

Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema

NAUnknownINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

March 31, 2020

Study Completion Date

April 30, 2020

Conditions
Lymphedema of Upper LimbBreast Cancer Related Lymphedema
Interventions
COMBINATION_PRODUCT

bupivacaine and triamcinolone

a mixture of 4 mL 0.5% bupivacaine (marcaine) and 1 mL 40 mg triamcinolone (kenacort-a)

Trial Locations (1)

34899

Canan Şanal-Toprak, Istanbul

Sponsors

Lead Sponsor

Marmara University
All Listed Sponsors
lead

Marmara University

OTHER

NCT04165512 - Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema | Biotech Hunter | Biotech Hunter